Sign inJoin waitlistJoin the waitlist

SL

Susan Lindemulder

Physician · Oregon Health & Science University School of Medicine

Credentials: · · · · ·

History

Oregon Health & Science University School of Medicine
2020–Present

Oregon Health & Science University
2008–2011
University of Colorado School of Medicine
2007–2008
University of Colorado School of Medicine
2000–2003
Northwestern University Woman's Medical School
1996–2000

Research

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's…
Blood · 2006 · 98 citations
Fever and neutropenia in pediatric patients with cancer
Review · Emergency Medicine Clinics of North America · 2009 · 43 citations
Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children's Oncology…
Pediatric Blood & Cancer · 2015 · First of 8 authors · 34 citations

LS
Linda Stork
5 papers
Kellee Parker
3 papers · 2 as a fellow
Jamie Aye
2 papers
JR
Jennifer Raybin
2 papers
Joseph Neglia
2 papers
Lucie Turcotte
2 papers
MW
Melinda Wu
2 papers
MV
Michael Vanderlind
2 papers
Monica Gramatges
2 papers
NK
Nina Kadan-Lottick
2 papers
Sharon Castellino
2 papers
Smita Bhatia
2 papers

Clinical trials

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2029
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Site PI · Recruiting
Children's Oncology Group
2023–2029
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Site PI · Recruiting
Children's Oncology Group
2023–2028